Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Endocrine Regulations
Volume 56 (2022): Issue 4 (October 2022)
Open Access
Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients
Suleyman Baldane
Suleyman Baldane
,
M Celik
M Celik
,
Levent Kebapcilar
Levent Kebapcilar
,
Suleyman Hilmi Ipekci
Suleyman Hilmi Ipekci
,
Sedat Abusoglu
Sedat Abusoglu
,
Huseyin Yilmaz
Huseyin Yilmaz
and
Husnu Alptekin
Husnu Alptekin
| Oct 20, 2022
Endocrine Regulations
Volume 56 (2022): Issue 4 (October 2022)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Oct 20, 2022
Page range:
265 - 270
DOI:
https://doi.org/10.2478/enr-2022-0028
Keywords
obesity
,
Cushing’s syndrome
,
screening
,
dexamethasone suppression test
© 2022 Suleyman Baldane et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.